What would it be like to meet the inventor of the investigational drug that is keeping you alive? Janet Freeman-Daily found out firsthand at the 2014 ASCO Annual Meeting.
Heather Von St. James and her family have turned the day she had surgery to treat mesothelioma into a huge celebration—Lung Leavin’ Day. In this guest post, she explains how adding a little humor to her cancer experience has taken away some of the fear.
Learn more about four studies that show the potential of new targeted therapies for advanced ovarian, lung, and thyroid cancers and chronic lymphocytic leukemia.
Get highlights of five studies showing promise in novel targeted therapies, cancer prevention, and patient care that will be presented at ASCO’s 50th Annual Meeting.
A recap of the highlights of 2013, including a list of the five most popular podcasts, articles, and recommendations for patients.